Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank13
3Y CAGR-20.3%
5Y CAGR-19.5%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-20.3%/yr
vs +1.5%/yr prior
5Y CAGR
-19.5%/yr
Consistent
Acceleration
-21.8pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $415.90M | -24.2% |
| 2024 | $548.71M | -14.6% |
| 2023 | $642.84M | -21.8% |
| 2022 | $821.58M | -21.8% |
| 2021 | $1.05B | -14.4% |
| 2020 | $1.23B | +71.1% |
| 2019 | $717.80M | -7.2% |
| 2018 | $773.86M | - |
| 2017 | $0.00 | - |